BMI can misread health risk for many people — and the problem is everything it leaves out
BMI can misread health risk for many people — and the problem is everything it leaves out
Body mass index has become one of medicine’s most durable shortcuts. With just height and weight, it turns very different bodies into neat categories: underweight, normal weight, overweight and obesity. That simplicity explains why BMI remains so common in clinics, research and public-health policy.
But the same feature that makes it useful also defines its limits. BMI is a blunt measure. It does not distinguish fat from muscle, it does not show where body fat is distributed, and it says little on its own about insulin resistance, inflammation, lipid abnormalities or broader metabolic status. In other words, it measures size relative to height, not body composition or biological risk in any complete sense.
That is why criticism of BMI used in isolation is growing. The most accurate reading of the evidence is not that BMI is useless or should be abandoned. It is more nuanced: BMI remains useful as a simple population-level screening tool, but it can misclassify some people when it is used as the main or only measure of overweight, obesity and cardiometabolic risk.
BMI works reasonably well for populations, but not always for individuals
Much of BMI’s value comes from public health. It allows researchers and clinicians to track trends, compare populations and estimate the prevalence of excess weight quickly. At that scale, simplicity is a real strength.
The problem appears when that same logic is applied too rigidly to an individual person. Two people with the same BMI can have very different body composition. One may carry more muscle, the other more fat. One may store more visceral abdominal fat, the other less. One may have multiple metabolic abnormalities, while the other may not show the same level of risk at that moment.
When all of that variation is compressed into one number, it can create a false sense of precision. The figure looks objective, but the biology remains more complicated than the chart suggests.
Waist circumference captures something BMI misses
One of the strongest messages in the supplied literature is the importance of waist circumference. A consensus statement included in the references argues that waist measurement provides independent and additive information beyond BMI, and that BMI alone is not sufficient for properly assessing or managing cardiometabolic risk.
That matters because fat distribution changes the clinical meaning of body size. Abdominal fat, especially visceral fat, is more strongly associated with type 2 diabetes, cardiovascular disease, inflammation and metabolic dysfunction than total body weight on its own.
In practice, two people with the same BMI may carry very different levels of risk if one stores more fat around the abdomen. That is precisely the kind of difference BMI cannot capture well. It tells you how heavy a person is relative to height, but not where the weight is carried or which tissue is most biologically concerning.
When BMI looks normal but risk is not
Another key concept supported by the references is “normal weight obesity”. The phrase sounds contradictory, but it describes a clinically important pattern: people whose BMI falls within the normal range, but who still have high body fat, metabolic dysfunction and elevated health risk.
This phenomenon exposes one of BMI’s biggest blind spots. A person can look “normal” by conventional BMI standards and still have a body composition and metabolic profile that place them at increased risk.
That means BMI can under-identify risk as well as overgeneralize it. It does not just sometimes label too broadly; it can also miss people whose risk is hidden behind a reassuring-looking number.
When BMI labels obesity but risk still varies
The problem also runs in the other direction. Research into obesity phenotypes suggests that not everyone classified as obese by BMI shares the same metabolic profile.
Some individuals clearly have a high-risk pattern, with hypertension, dysglycemia, dyslipidemia and other abnormalities. Others, at least at a given point in time, may not show the same degree of dysfunction. That does not mean excess adiposity is harmless or that risk cannot evolve over time. But it does show that BMI categories can group together biologically different people under one label.
That matters because the same BMI threshold does not always carry the same clinical meaning in every body.
The real issue is not just body size, but composition and metabolic context
The BMI debate is often framed too crudely, as if the question were whether it “works” or “doesn’t work”. The more useful point is that BMI measures part of the problem, not the whole of it.
Risk related to adiposity depends on several factors beyond body weight relative to height. Body fat percentage matters. Visceral fat matters. Muscle mass matters. Fitness matters. So do blood pressure, glucose control, lipid levels, liver health and other metabolic markers.
That is why judging overweight or obesity using BMI alone can lead to incomplete decisions. And that incompleteness is exactly what the current discussion is trying to address.
Metabolic health is not fixed over time
Another important nuance is that metabolic phenotypes do not stay still. Someone who appears metabolically less vulnerable today may shift over time because of aging, inactivity, poor sleep, menopause, muscle loss or worsening insulin resistance.
That means even classifications more sophisticated than BMI are still snapshots. Cardiometabolic risk is dynamic. No single measurement tells the whole story forever.
This matters because it prevents one simplistic tool from being replaced with another simplistic tool. The strongest conclusion is not that one perfect alternative now exists. It is that health assessment improves when multiple measures are considered together.
What should be used alongside BMI
The references point in a fairly practical direction: BMI should not be used on its own.
Waist circumference helps identify abdominal fat. Body fat percentage can offer a more refined picture in some settings. Metabolic markers such as blood glucose, hemoglobin A1c, blood pressure and lipid profile show whether the body is already expressing signs of higher cardiometabolic risk.
None of these tools is perfect. Waist measurement depends on technique. Body fat estimates are not always easy to obtain. Metabolic markers also have limitations and can shift over time. But together they provide a far more informative picture than BMI alone.
What this changes in clinical practice
The practical message is not to throw BMI out, but to use it more intelligently.
As an initial screening tool, it still has clear value. It is quick, inexpensive and easy to standardize across clinics and populations. The mistake comes when it is treated as a complete verdict on someone’s health.
If the goal is to assess individual risk — especially cardiometabolic risk — BMI works better when interpreted alongside waist size, body composition, blood pressure, glucose, lipid levels, medical history and lifestyle.
That can also improve the conversation between clinicians and patients. Instead of reducing health to a chart category, assessment becomes more closely matched to the body in front of the clinician and the risk that person actually carries.
This debate does not weaken the obesity story — it sharpens it
One of the most useful effects of this shift in thinking is that it moves attention away from a single number and towards actual biological risk. That does not make overweight or obesity less important as health issues. If anything, it makes the conversation more accurate.
When BMI is treated as if it captures the whole story, medicine risks making two mistakes at once: over-alarming some people without describing their risk very well, and falsely reassuring others whose risk is hidden behind a normal-range BMI.
Better medicine should aim to miss fewer people in both directions.
The most balanced takeaway
The supplied evidence supports the idea that BMI can misclassify some individuals when it is used as the main measure of overweight, obesity and cardiometabolic risk. It does not capture body fat percentage, fat distribution or metabolic health, which means it can miss higher-risk people and overgeneralize across biologically different ones.
But that does not mean BMI should be discarded. It still has a clear role as a simple population-level screening measure. The problem begins when it is treated as sufficient on its own.
So the strongest conclusion is not that BMI should be abandoned, but that it should be put in its proper place: a useful starting point, not a complete answer. To understand real health risk, clinicians often need to look beyond BMI to waist circumference, body composition and broader metabolic profiling. That is where the actual body begins to appear behind the number.